Display options
Cite
Rost K, Marshall D, Shearer B, et al. Depression care management: can employers purchase improved outcomes?. Depress Res Treat. 2011;2011:942519doi: 10.1155/2011/942519.
Rost, K., Marshall, D., Shearer, B., & Dietrich, A. J. (2011). Depression care management: can employers purchase improved outcomes?. Depression research and treatment, 2011942519. https://doi.org/10.1155/2011/942519
Rost, Kathryn, et al. "Depression care management: can employers purchase improved outcomes?." Depression research and treatment vol. 2011 (2011): 942519. doi: https://doi.org/10.1155/2011/942519
Rost K, Marshall D, Shearer B, Dietrich AJ. Depression care management: can employers purchase improved outcomes?. Depress Res Treat. 2011;2011:942519. doi: 10.1155/2011/942519. Epub 2011 Jun 08. PMID: 21738872; PMCID: PMC3123993.
Copy Download .nbib Format: NLM
Share it on

Depress Res Treat. 2011;2011:942519. doi: 10.1155/2011/942519. Epub 2011 Jun 08.

Depression care management: can employers purchase improved outcomes?.

Depression research and treatment

Kathryn Rost, Donna Marshall, Benjamin Shearer, Allen J Dietrich

Affiliations

  1. Department of Mental Health Law and Policy, College of Behavioral and Community Sciences, University of South Florida, Tampa, FL 33612, USA.

PMID: 21738872 PMCID: PMC3123993 DOI: 10.1155/2011/942519

Abstract

Fourteen vendors are currently selling depression care management products to US employers after randomized trials demonstrate improved work outcomes. The research team interviewed 10 (71.4%) of these vendors to compare their products to four key components of interventions demonstrated to improve work outcomes. Five of 10 depression products incorporate all four key components, three of which are sold by health maintenance organizations (HMOs); however, HMOs did not deliver these components at the recommended intensity and/or duration. Only one product delivered by a disease management company delivered all four components of care at the recommended intensity and duration. This "voltage drop," which we anticipate will increase with product implementation, suggests that every delivery system should carefully evaluate the design of its depression product before implementation for its capacity to deliver evidence-based care, repeating these evaluations as new evidence emerges.

References

  1. JAMA. 2007 Sep 26;298(12):1401-11 - PubMed
  2. Arch Gen Psychiatry. 2006 Dec;63(12):1345-53 - PubMed
  3. Am J Psychiatry. 2006 Sep;163(9):1561-8 - PubMed
  4. JAMA. 2003 Jun 18;289(23):3135-44 - PubMed
  5. Arch Gen Psychiatry. 2005 Jun;62(6):629-40 - PubMed
  6. Am J Psychiatry. 2004 Oct;161(10):1885-91 - PubMed
  7. Gen Hosp Psychiatry. 2004 May-Jun;26(3):190-8 - PubMed
  8. Med Care. 2006 Apr;44(4):352-8 - PubMed
  9. J Occup Environ Med. 2001 Mar;43(3):218-25 - PubMed
  10. Am J Manag Care. 2007 Feb;13(2):105-12 - PubMed
  11. J Clin Epidemiol. 2008 Jul;61(7):679-87 - PubMed
  12. J Occup Environ Med. 1999 Oct;41(10):863-77 - PubMed
  13. Soc Psychiatry Psychiatr Epidemiol. 1996 Jan;31(1):3-9 - PubMed
  14. Med Care. 2004 Dec;42(12):1202-10 - PubMed
  15. BMC Health Serv Res. 2010 Jan 19;10:19 - PubMed
  16. Health Econ. 2002 Apr;11(3):221-31 - PubMed
  17. Int J Health Care Finance Econ. 2011 Mar;11(1):55-81 - PubMed
  18. Br J Psychiatry. 2006 Dec;189:484-93 - PubMed
  19. Arch Intern Med. 2006 Nov 27;166(21):2314-21 - PubMed
  20. Depress Anxiety. 2010;27(1):78-89 - PubMed
  21. Br J Psychiatry. 2006 Oct;189:297-308 - PubMed
  22. Health Rep. 2007 Feb;18(1):9-22 - PubMed

Publication Types

Grant support